HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy

Prediction of breast cancer response to Neoadjuvant Chemotherapy (NACT) is an urgent need to promptly direct non-responder patients to alternative therapies. Infiltrating T lymphocytes, namely cytotoxic T lymphocytes (CTLs) have been appointed as predictors of response. However, cancer cells have th...

ver descrição completa

Detalhes bibliográficos
Autor principal: Saraiva, DP (author)
Outros Autores: Jacinto, A (author), Borralho, P (author), Braga, S (author), Cabral, MG (author)
Formato: article
Idioma:eng
Publicado em: 2019
Assuntos:
Neoplasias da Mama
Terapia Neoadjuvante
Linfócitos T Citotóxicos
Antígenos HLA-DR
HLA-DR Antigens
Neoadjuvant Therapy
T-Lymphocytes, Cytotoxic
Breast Neoplasms
Texto completo:http://hdl.handle.net/10400.26/25642
País:Portugal
Oai:oai:comum.rcaap.pt:10400.26/25642

Texto Completo

http://hdl.handle.net/10400.26/25642

Registros relacionados